首页|腔内灌注治疗恶性胸腔积液的研究现状

腔内灌注治疗恶性胸腔积液的研究现状

扫码查看
恶性胸腔积液(MPE)是恶性肿瘤常见的相关并发症,一旦出现就提示病情进入了恶化阶段,临床治疗存在非常大的困难,因常可伴随引起胸痛胸闷、喘气等多种症状,耐受力明显下降,严重影响患者的生存质量及预后。目前,胸腔内直接局部灌注抗肿瘤药物的治疗方法应用较为广泛。本文从胸膜硬化剂、热疗、化疗药物、生物免疫抑制剂、中药制剂、抗血管生成剂及载药囊泡等方面入手,分析各类药物的特点及临床应用,以期为未来MPE的研究及治疗提供一定的参考依据。
Research Status of Intracavitary Perfusion in the Treatment of Malignant Pleural Effusion
Malignant pleural effusion(MPE)is a common complication of malignant tumors.Once it occurs,it indicates that the condition has entered a stage of deterioration.There are great difficulties in clinical treatment.Because it can often be accompanied by chest pain,chest tightness,wheezing and other symptoms,the tolerance is significantly reduced,which seriously affects the quality of life and prognosis of patients.At present,the treatment of intrapleural direct local perfusion of antitumor drugs is widely used.In this paper,the characteristics and clinical application of various drugs are analyzed from the aspects of pleural sclerosing agent,hyperthermia,chemotherapeutic drugs,biological immunosuppressive agents,traditional Chinese medicine preparations,anti-angiogenic agents and drug-loaded vesicles,in order to provide some reference for the future research and treatment of MPE.

Perfusion therapyMalignant pleural effusionVesiclesHeat treatmentEndostatin

雷希君、罗利琼

展开 >

武汉科技大学附属天佑医院肿瘤科,湖北武汉 430064

灌注治疗 恶性胸腔积液 囊泡 热疗 恩度

2024

医学信息
国家卫生部信息化管理领导小组 中国电子学会中国医药信息学分会 陕西文博生物信息工程研究所

医学信息

影响因子:0.161
ISSN:1006-1959
年,卷(期):2024.37(3)
  • 39